EMA Medicine safety communications
Xeloda / Capecitabine Accord / Capecitabine Medac / Capecitabine Teva / Ecansya (previously Capecitabine Krka) / Teysuno: referral - article 31
Published by European Medicines Agency: · Ref. EMEA/H/A-31/1488
Summary
Referral - Article 31
- Related referral: Fluorouracil and fluorouracil related substances (capecitabine, tegafur and flucytosine) containing medicinal products
Medicine
Xeloda / Capecitabine Accord / Capecitabine Medac / Capecitabine Teva / Ecansya (previously Capecitabine Krka) / Teysuno
- Category
- Medicine safety communications
- Product type
- Human medicine
- Active substance(s): Fluorouracil;capecitabine;tegafur
- ATC code: L01BC06;L01BC53;L01BC02
Measures and alternatives
- Regulatory outcome: Variation
Source: EMA — medicine safety communications — European Medicines Agency
Source: European Medicines Agency (EMA). Reproduced with acknowledgement of the source, in line with the EMA legal notice. EU Safety Radar is an independent information service; the text above presents the official data in the original language — the notice published by the authority is authoritative.
Open the original notice (www.ema.europa.eu) ↗